These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38970287)

  • 1. Severe Vasoplegic Shock After Heart Transplant Successfully Treated With Multimodal Therapeutic Approach.
    Jenkins FS; Aubin H; Boeken U; Lichtenberg A
    Exp Clin Transplant; 2024 May; 22(5):406-408. PubMed ID: 38970287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
    Cutler NS; Rasmussen BM; Bredeck JF; Lata AL; Khanna AK
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2756-2762. PubMed ID: 32868151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylene blue therapy for vasoplegia after cardiac surgery].
    Skuza K; Chmielniak S; Dziuk W; Kucewicz E; Pawlak S; Knapik P
    Anestezjol Intens Ter; 2009; 41(3):159-62. PubMed ID: 19999604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
    Feih JT; Rinka JRG; Zundel MT
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.
    Graham RE; Cartner M; Winearls J
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting.
    Sovic W; Mathew C; Blough B; Monday KA; Sam T; Zafar H; Guerrero-Miranda C; Sherwood M; Hebert C; Hall S; Alam A
    Methodist Debakey Cardiovasc J; 2021; 17(4):98-101. PubMed ID: 34824689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report.
    Vilalva KH; Mumic FT; Silveira MRG; Mente ED; Evora PRB; Castro E Silva O
    Exp Clin Transplant; 2018 Aug; 16(4):511-514. PubMed ID: 27561907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoplegia from Continuous Flow Left Ventricular Assist Devices.
    Sathianathan S; Bhat G; Dowling R
    Curr Cardiol Rep; 2021 Jul; 23(8):101. PubMed ID: 34196837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene blue treatment for resistant shock following renal transplantation.
    Hershman E; Hadash A; Attias O; Ben-Ari J
    Paediatr Anaesth; 2015 Nov; 25(11):1168-9. PubMed ID: 26428738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin Complex Concentrate and Methylene Blue for Treatment of Coagulopathy and Vasoplegia in a Pediatric Heart Transplant Patient.
    Lee JK; Ing C
    A A Case Rep; 2016 Mar; 6(5):127-9. PubMed ID: 26599739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
    Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
    Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.
    Weinberg D; Running K; Kalarickal PL; Patel GP
    Transplant Proc; 2021 May; 53(4):1300-1302. PubMed ID: 33246585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
    Farina Junior JA; Celotto AC; da Silva MF; Evora PR
    Med Sci Monit; 2012 May; 18(5):HY13-7. PubMed ID: 22534716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.